Biosimilar Development solution center
-
Emerging Trends In mAbs Manufacturing In 2025 And Beyond
2/11/2025
Two key innovations — continuous perfusion in upstream processing and multicolumn chromatography in downstream processing — are having a profound impact on biologics manufacturing.
-
Clinical Regulatory Changes One Of Many Tailwinds For Biosimilars
2/10/2025
With an projected global market value of $35.7 billion in 2025, biosimilars are slated for considerable growth opportunities, thanks in part to clinical regulatory changes.
-
Improving Bioprocess Monitoring And Control With Multivariate Data Analysis
12/9/2024
Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.
-
Optimize Your RFP To Ensure Successful Biologic Development
11/5/2024
Creating a thorough, comprehensive RFP will help a CDMO partner lay the foundation for a productive partnership, fulfill your goals, and help ensure future market success for your therapeutic.
-
Choose The Right CDMO To Guide Your Biologic To Regulatory Success
11/5/2024
If you are wondering when to begin your CDMO search, the answer is simple: the sooner the better. Partnering with a CDMO early helps ensure later success.
-
3 Ways To Maximize The Benefits Of Your CDMO Partnership
11/5/2024
An experienced CDMO partner can help bridge the gap from lab scale to clinical and commercial scale while sharing the critical insights needed to launch a biologic manufacturing program.
-
End-To-End Analytical Solutions For Biologic Development
10/24/2024
Partner with Mabion for comprehensive, state-of-the-art analytical services that ensure quality, safety, and regulatory compliance throughout every stage of your biologic drug’s lifecycle.
-
From Tech Transfer To Validation: One CDMO's Client-Centric Approach To Development
9/23/2024
If you’re looking to work with a CDMO that can help you save money and ensure efficiency in your therapeutic production, consider the benefits of choosing a Polish partner.
-
The Crucial Role Of Downstream Processing In Optimizing RNA-LNP Drug Development
8/28/2024
Explore the key aspects of lipid nanoparticle (LNP) development, including the essential downstream processes of Tangential Flow Filtration (TFF) and normal flow filtration.
-
Drug Product Formulation & Process Development: The Must-Have Skills At A Glance
8/26/2024
Specialists in drug product formulation and process development at small biopharmas need to balance scientific knowledge and multidisciplinary know-how across the stages of product development.